GC Therapeutics’ plug-and-play stem cell progr
Browsing: All news
Category Added in a WPeMatico Campaign
Global industry leaders converge in Singapore to
As the International Longevity Summit approaches
Phase 2 study data indicates ‘dose-dependent i
Company aims to inhibit SARM1 enzyme to prevent
Designed to protect key retinal cells, company’s Fas inhibitor drugs aim to prevent vision loss in a range of conditions. With the world buzzing about Neuralink’s latest project to restore sight to the blind, others take the view that prevention…
Collaboration aims to empower health practitione
Coya Therapeutics is pioneering multi-pathway th
Elon Musk claims that experimental ‘Blindsight
Boosting cellular regeneration, reducing inflamm